MEP54308A - Aerosolna formulacija za inhaliranje koja sadrži triotropijumovu so - Google Patents

Aerosolna formulacija za inhaliranje koja sadrži triotropijumovu so

Info

Publication number
MEP54308A
MEP54308A MEP-543/08A MEP54308A MEP54308A ME P54308 A MEP54308 A ME P54308A ME P54308 A MEP54308 A ME P54308A ME P54308 A MEP54308 A ME P54308A
Authority
ME
Montenegro
Prior art keywords
inhalation
aerosol formulation
tiotropium salt
active substance
tiotropium
Prior art date
Application number
MEP-543/08A
Other languages
English (en)
Inventor
Karin Drechsel
Barbara Niklaus-Humke
Christel Schmelzer
Petra Barth
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28458728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP54308(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MEP54308A publication Critical patent/MEP54308A/hr
Publication of ME00359B publication Critical patent/ME00359B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nozzles (AREA)

Abstract

Ovaj pronalazak odnosi se na aerosolnu formulaciju bez potisnog gasa, farmaceutski prihvatljive soli tiotropijuma, rastvorene u vodi. Formulacija, na osnovu pronalaska, naročito je pogodna za prevođenje djelotvorne supstance u stanje magle, pomoću atomizera (raspršivača, sprejera), da bi djelotvorna supstanca mogla da se primijeni inhalativno, prvenstveno kod astme i COPD-a.
MEP-2008-543A 2002-04-11 2003-04-02 Aerosolna formulacija za inhaliranje koja sadrži so tiotropijuma ME00359B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10216036A DE10216036A1 (de) 2002-04-11 2002-04-11 Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
PCT/EP2003/003438 WO2003084519A2 (de) 2002-04-11 2003-04-02 Aerosolformulierung für die inhalation enthaltend ein tiotropiumsalz
YUP-879/04A RS50923B (sr) 2002-04-11 2003-04-02 Aerosolna formulacija za inhaliranje koja sadrži so tiotropijuma

Publications (2)

Publication Number Publication Date
MEP54308A true MEP54308A (hr) 2011-05-10
ME00359B ME00359B (me) 2011-10-10

Family

ID=28458728

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2008-543A ME00359B (me) 2002-04-11 2003-04-02 Aerosolna formulacija za inhaliranje koja sadrži so tiotropijuma

Country Status (33)

Country Link
EP (2) EP1949892A1 (hr)
JP (1) JP2005531528A (hr)
KR (1) KR100997219B1 (hr)
CN (1) CN1309378C (hr)
AR (1) AR039286A1 (hr)
AT (1) ATE389391T1 (hr)
AU (1) AU2003222791B2 (hr)
BR (1) BR0309080A (hr)
CA (1) CA2473815C (hr)
CO (1) CO5611150A2 (hr)
CY (1) CY1108133T1 (hr)
DE (2) DE10216036A1 (hr)
DK (1) DK1496876T3 (hr)
EA (1) EA007228B1 (hr)
EC (1) ECSP045358A (hr)
ES (1) ES2303897T3 (hr)
HK (1) HK1078793A1 (hr)
HR (1) HRP20040932B1 (hr)
ME (1) ME00359B (hr)
MX (1) MXPA04009818A (hr)
MY (1) MY137249A (hr)
NO (1) NO334915B1 (hr)
PE (1) PE20030970A1 (hr)
PL (1) PL371204A1 (hr)
PT (1) PT1496876E (hr)
RS (1) RS50923B (hr)
SA (1) SA03240192B1 (hr)
SI (1) SI1496876T1 (hr)
TW (1) TWI344851B (hr)
UA (1) UA78994C2 (hr)
UY (1) UY27754A1 (hr)
WO (1) WO2003084519A2 (hr)
ZA (1) ZA200405721B (hr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1682541T1 (sl) 2003-11-03 2010-06-30 Boehringer Ingelheim Int Postopek za pripravo tiotropijevih soli
AU2006277968A1 (en) * 2005-08-06 2007-02-15 Boehringer Ingelheim International Gmbh Use of tiotropium salts in the treatment of severe persistant asthma
US20070088030A1 (en) 2005-10-10 2007-04-19 Barbara Niklaus-Humke Aerosol formulations for the inhalation of beta-agonists
EP1905440A1 (de) * 2006-09-06 2008-04-02 Boehringer Ingelheim Pharma GmbH & Co. KG Verwendung einer pharmazeutischen Zusammensetzung enthaltend ein Anticholinergikum zur Abtötung von Mikroorganismen und zur Behandlung von Atemwegsinfektionen
EP2044967A1 (de) * 2007-10-01 2009-04-08 Boehringer Ingelheim Pharma GmbH & Co. KG Zerstäuber
WO2013127738A1 (de) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Neue treibgashaltige tiotropium-formulierung
RU2493827C1 (ru) * 2012-10-03 2013-09-27 Шолекс Девелопмент Гмбх Стабильный комбинированный раствор фенотерола гидробромида и ипратропия бромида
WO2015065223A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Стабильный раствор фенотерола гидробромида
WO2015065219A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Раствор ипратропия бромида
GB201507686D0 (en) * 2015-05-05 2015-06-17 Norton Healthcare Ltd A stable tiotropium nebuliser solution
MX2019005563A (es) * 2016-11-16 2019-08-12 Glenmark Specialty Sa Tiotropio nebulizado.
WO2021188809A1 (en) * 2020-03-19 2021-09-23 Cai Gu Huang Inhalable formulation of a solution containing levalbuterol tartrate
CN114259481A (zh) * 2021-11-26 2022-04-01 南京华盖制药有限公司 一种奥达特罗复方吸入溶液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
IL107120A (en) 1992-09-29 1997-09-30 Boehringer Ingelheim Int Atomising nozzle and filter and spray generating device
DE19536903C2 (de) 1995-10-04 1998-09-10 Boehringer Ingelheim Int Vorrichtung zum Haltern eines fluidischen Bauteils
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19545226C1 (de) 1995-12-05 1997-06-19 Boehringer Ingelheim Int Sperrspannwerk für einen federbetätigten Abtrieb
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE19742439C1 (de) 1997-09-26 1998-10-22 Boehringer Ingelheim Int Mikrostrukturiertes Filter
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
CN100396285C (zh) * 2000-10-31 2008-06-25 贝林格尔英格海姆法玛两合公司 包含噻托铵盐溶液的可吸入制剂

Also Published As

Publication number Publication date
PE20030970A1 (es) 2004-01-13
TWI344851B (en) 2011-07-11
CO5611150A2 (es) 2006-02-28
TW200401653A (en) 2004-02-01
HRP20040932A2 (en) 2005-02-28
CA2473815A1 (en) 2003-10-16
PL371204A1 (en) 2005-06-13
ME00359B (me) 2011-10-10
UA78994C2 (uk) 2007-05-10
ES2303897T3 (es) 2008-09-01
KR20040097322A (ko) 2004-11-17
CN1309378C (zh) 2007-04-11
MXPA04009818A (es) 2004-12-13
NO20044001L (no) 2004-10-27
MY137249A (en) 2009-01-30
AR039286A1 (es) 2005-02-16
WO2003084519A2 (de) 2003-10-16
ATE389391T1 (de) 2008-04-15
CN1646108A (zh) 2005-07-27
EP1496876B1 (de) 2008-03-19
EP1496876A2 (de) 2005-01-19
KR100997219B1 (ko) 2010-11-29
CA2473815C (en) 2011-06-14
EP1949892A1 (de) 2008-07-30
UY27754A1 (es) 2003-11-28
CY1108133T1 (el) 2014-02-12
HK1078793A1 (en) 2006-03-24
JP2005531528A (ja) 2005-10-20
NO334915B1 (no) 2014-07-14
ECSP045358A (es) 2004-11-26
DE10216036A1 (de) 2003-10-23
ZA200405721B (en) 2006-05-31
WO2003084519A3 (de) 2003-12-24
BR0309080A (pt) 2005-02-22
AU2003222791A1 (en) 2003-10-20
RS87904A (en) 2006-12-15
EA007228B1 (ru) 2006-08-25
RS50923B (sr) 2010-08-31
HRP20040932B1 (hr) 2013-04-30
SA03240192B1 (ar) 2008-01-09
EA200401305A1 (ru) 2005-06-30
DE50309414D1 (de) 2008-04-30
DK1496876T3 (da) 2008-06-02
AU2003222791B2 (en) 2008-09-25
PT1496876E (pt) 2008-04-15
SI1496876T1 (sl) 2008-08-31

Similar Documents

Publication Publication Date Title
MEP54308A (hr) Aerosolna formulacija za inhaliranje koja sadrži triotropijumovu so
HRP20120286T1 (hr) Kombinacija antikolinergika i inhibitora fosfodiesteraze tip 4 za liječenje respiratornih bolesti
WO2007123955A3 (en) Stable hydroalcoholic oral spray formulations and methods
WO2008013929A3 (en) Anti-migraine oral spray formulations and methods
US20180256560A1 (en) Liquid nicotine formulation
EP1089715B8 (en) Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
UA103028C2 (ru) Портативный ингалятор для распыления лекарственного препарата без использования газа-пропеллента
WO2011141929A3 (en) Aqueous pharmaceutical compositions of fluticasone and olopatadine
WO2008053253A3 (en) Inhaler devices and bespoke pharmaceutical compositions
JP2007513959A5 (hr)
HU228494B1 (en) Use of aqueous medicaments for the production of propellent gas-free aerosols
TW200718707A (en) Substituted phenylphosphates as mutual prodrugs of steroids and β-agonists for the treatment of pulmonary inflammation and bronchoconstriction
NZ593695A (en) Alkaloid aminoester derivatives and medicinal composition thereof
DK1814538T3 (da) Fremgangsmåde til administration af næsespray
GEP20166479B (en) Aerosol formulation for copd
DK1572153T3 (da) Fremstilling af sterile vandige suspensioner, som omfatter mikroniserede krystallinske virksomme stoffer til inhalering
WO2005025535A8 (en) Methods for preparing pharmaceutical compositions
NZ597920A (en) Anhydrate of tiotropium bromide
BR112014008602A2 (pt) composição farmacêutica, recipiente vedado, inalador de dosagem medida, métodos para o tratamento de um paciente que sofre ou provavelmente sofre de um distúrbio respiratório, e, método para fabricação de uma composição farmacêutica
JOP20200314A1 (ar) تركيبات صيدلانية مستقرة لأجهزة إستنشاق جرعات مضغوطة معايرة الجرعة
YU33103A (sh) Formulacija rastvora za inhalaciju sa soli tiotropijuma
YU33003A (sh) Formulacija rastvora za inhalaciju sa soli tiotropijuma
CN105925125A (zh) 一种具有香味的油漆
WO2004026362A3 (en) Dri nasal sprays
WO2022006028A3 (en) Pharmaceutical formulation containing combination of m3 antagonist-beta-2 agonist and inhaled corticosteroids